← 返回

慢性病毒感染及其在塑造肿瘤免疫微环境中的作用

英文原题:Chronic viral infections and their role in shaping the tumor immune microenvironment.

查看英文原题

Chronic viral infections and their role in shaping the tumor immune microenvironment.

PubMed 2026/03/16(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

慢性病毒感染,如HBV、HCV、EBV和HPV,不仅通过直接致癌作用促进肿瘤发生,还通过复杂的免疫调节机制重塑肿瘤免疫微环境(TIME)。这些感染增强免疫抑制并促进转移。病毒诱导调节性T细胞(Tregs)、髓源性抑制细胞(MDSCs)和免疫抑制细胞因子的积累,同时驱动CD8+ T细胞耗竭并损害NK细胞功能,创造有利于肿瘤存活的免疫环境。慢性炎症、促血管生成因子以及外泌体和微囊泡介导的信号进一步重塑局部和远处微环境,形成支持肿瘤细胞定植和转移的“转移前生态位”。关键信号通路,包括NF-κB、STAT3、PD-1/PD-L1和TGF-β,被HBx和LMP1等病毒蛋白持续激活,强化免疫抑制和转移。基于这些机制,抗病毒治疗与免疫检查点抑制剂(ICIs)联合或靶向外泌体和免疫抑制通路的策略显示出增强抗肿瘤免疫和限制转移的潜力。更深入地理解病毒-免疫-转移轴及相关生物标志物可能为病毒相关癌症提供精准免疫治疗策略并改善患者预后。

展开英文摘要原文

Chronic viral infections, such as HBV, HCV, EBV, and HPV, contribute to tumorigenesis not only through direct oncogenic effects but also by reshaping the tumor immune microenvironment (TIME) via complex immunoregulatory mechanisms. These infections enhance immune suppression and promote metastasis. Viruses induce the accumulation of regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), and immunosuppressive cytokines, while driving CD8 + T cell exhaustion and impairing NK cell function, creating an immune environment favorable for tumor survival. Chronic inflammation, pro-angiogenic factors, and signals mediated by exosomes and microvesicles further remodel local and distant microenvironments, forming a "pre-metastatic niche" that supports tumor cell colonization and metastasis.

Key signaling pathways, including NF-κB, STAT3, PD-1/PD-L1, and TGF-β, are persistently activated by viral proteins such as HBx and LMP1, reinforcing immunosuppression and metastasis. Based on these mechanisms, combined strategies of antiviral therapy with immune checkpoint inhibitors (ICIs) or targeting exosomes and immunosuppressive pathways show potential to enhance antitumor immunity and limit metastasis.

A deeper understanding of the virus-immune-metastasis axis and related biomarkers may provide precise immunotherapeutic strategies for virus-associated cancers and improve patient outcomes.

论文信息

作者
Li H、Jiang X、Zhang Q、Yuan Y
单位
Department of Oncology, The Affiliated Jiangning Hospital with Nanjing Medical University, Nanjing, Jiangsu, China.China
文献类型
综述
期刊
Frontiers in immunology2026
原文标识
PubMed 41918722 · DOI 10.3389/fimmu.2026.1810902